[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609737":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":18,"centralContacts":24,"locations":34,"responsibleParty":55,"collaborators":58,"id":64,"slug":7,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":7,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":7,"enrollmentInfo":72,"targetDuration":7,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":7,"overallStatus":36,"whyStopped":7,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Medical University of South Carolina","OTHER",null,[9,13,15],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BEHAVIORAL","CBT4CBT (Computerized Cognitive Behavioral Therapy)","Participants will receive one therapist-led motivational interviewing\u002Fgoal setting session followed by 7 sessions of computerized CBT4CBT.",{"type":10,"name":14,"description":12,"armGroupLabels":7,"otherNames":7},"Motivational Interviewing",{"type":10,"name":16,"description":17,"armGroupLabels":7,"otherNames":7},"Contingency Management","Patients will receive contingent reinforcers (financial incentives for reduction in urinary cannabinoids).",[19,22],{"name":20,"affiliation":5,"role":21},"Rachel Tomko, PhD.","PRINCIPAL_INVESTIGATOR",{"name":23,"affiliation":5,"role":21},"Erin McClure, PhD.",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":7,"email":29},"Rachel Tomko, PhD","CONTACT","(843) 792-5447","tomko@musc.edu",{"name":31,"role":27,"phone":32,"phoneExt":7,"email":33},"Erin McClure, PhD","(843) 792-7192","mccluree@musc.edu",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Charleston","South Carolina","29425","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-79.93275,32.77632,{"lat":46,"lon":45},[49,53],{"name":50,"role":27,"phone":51,"phoneExt":7,"email":52},"Kevin Branson, MA, ADC, MAC","843-792-0493","bransonk@musc.edu",{"name":26,"role":27,"phone":54,"phoneExt":7,"email":29},"843-792-5447",{"type":21,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Rachel Tomko","Associate Professor-Faculty",[59,62],{"name":60,"class":61},"National Institutes of Health (NIH)","NIH",{"name":63,"class":61},"National Institute on Drug Abuse (NIDA)","100609737",false,"NCT07218471","Cannabis Reduction and Functional Outcomes","Prospective Changes in Patient-reported and Objective Functioning Following Reduction of Cannabis Use","Inclusion Criteria:\n\n* Age 18+\n* Urinary cannabinoid level ≥ 50 ng\u002FmL\n* DSM-5 diagnosis of CUD (mild, moderate, or severe)\n* Willingness to attempt cannabis reduction\n* Completion of Intake Visit\n\nExclusion Criteria:\n\n* Serious medical\u002Fpsychiatric conditions\n* Pregnancy or breastfeeding\n* Use of cannabis in past 30 days was for medical purposes only\n* Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition\n* Cognitive or understanding difficulties, as evidenced by inability to pass informed consent quiz","ALL","18 Years",{"count":73,"type":74},176,"ESTIMATED","INTERVENTIONAL",[77],"NA","This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.",[80],"Cannabis Use Disorder","2026-03-16",{"date":83,"type":84},"2026-03-19","ACTUAL",{"date":86,"type":84},"2026-03-13",{"date":88,"type":74},"2030-01-30",{"name":5,"class":6},1]